Skip to main content
AZN logo
AZN
(NYSE)
AstraZeneca PLC
$168.27-- (--)
Loading... - Market loading

AstraZeneca (AZN) Stock Price & Financial Analysis

AstraZeneca Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$166.04 - $169.49
52-Week High$212.71
52-Week Low$71.49
Open$166.37
Volume2.39M
Average Volume (3M)2.42M
Market Cap525.34B
Shares Outstanding3.12B
P/E Ratio (TTM)50.57
Forward P/E38.03
Price to Sales (P/S)8.69
Price to Book (P/B)11.10
EV/EBITDA27.31
Revenue (TTM)60.44B
Net Income (TTM)10.39B
Free Cash Flow (TTM)7.75B
EPS (TTM)$3.33
Profit Margin17.19%
Operating Margin23.69%
Return on Equity (ROE)21.95%
Debt to Equity0.68
50-Day MA$180.79
200-Day MA$173.47
52-Week Change130.51%
Annual Dividend$7.43
Dividend Yield4.42%
Payout Ratio200.00%
Last Dividend Ex-DateMar 23, 2027

Frequently Asked Questions About AstraZeneca

What is the current stock price for AZN?

As of the latest trading session, AZN stock trades at $168.27. The 52-week range is $71.49–$212.71, with a day range of $166.04–$169.49.

What is the P/E ratio for AZN?

AstraZeneca's trailing P/E ratio is 50.6, meaning investors pay $50.6 for every $1 of annual earnings. The forward P/E is 38.0, reflecting analyst expectations for future earnings. AstraZeneca operates in the Healthcare sector.

Does AZN pay dividends?

Yes, AstraZeneca pays a 4.42% annual dividend yield ($7.43 per share). The payout ratio is 200.0%. The last ex-dividend date was 2027-03-23.

What do analysts recommend for AZN?

Based on 23 analysts, the consensus for AZN is Buy.

What is the market cap of AZN?

AstraZeneca's market capitalization is $525.34B, classifying it as a mega-cap company. AstraZeneca operates in the Healthcare sector within the Drug Manufacturers - General industry.